quantisnow
FeedTopReportsPricing
⌘K
Live feed
07:56:07·14h
ANALYSTRating
First Tracks Biotherapeutics Inc. logo

Analyst initiated coverage on First Tracks Biotherapeutics with a new price target

TRAX· First Tracks Biotherapeutics Inc.
Health Care
Original source

Companies

  • TRAX
    First Tracks Biotherapeutics Inc.
    Health Care

Recent analyst ratings

  • Apr 23UpdateAnalyst$31.00
  • Apr 22UpdateBarclays$40.00
  • Apr 21UpdateUBS$45.00

Related

  • INSIDER4h
    SEC Form 3 filed by new insider Tamboli Ajim
  • INSIDER4h
    SEC Form 4 filed by Chief Financial Officer Tamboli Ajim
  • SEC1d
    SEC Form SCHEDULE 13G filed by First Tracks Biotherapeutics Inc.
  • INSIDER1d
    SEC Form 4 filed by Ecor1 Capital, Llc
  • INSIDER1d
    SEC Form 3 filed by new insider Ecor1 Capital, Llc
  • INSIDER1d
    SEC Form 3 filed by new insider Stone Benjamin
  • INSIDER1d
    SEC Form 4 filed by Ware J. Anthony
  • INSIDER1d
    SEC Form 4 filed by Lizzul Paul F.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022